This content is current only at the time of printing. This document was printed on 19 June 2021. A current copy is located at https://apvma.gov.au/node/27866
You are here
Regulatory Update #261
Opportunities and challenges for regulatory science, technology and innovation
Our recent Chief Scientist blog summarises how changes in science, technology and innovation impact APVMA regulation.
These issues were discussed at the APVMA industry sessions in September. Topics included nanotechnology, biotechnology, bio-pesticides, stem cell therapies and gene therapies. By engaging with industry and stakeholders to understand emerging sciences, our work can evolve in unison with developments in the agvet industry.
APVMA participation at international steering committee in Tokyo
Next week our interim CEO, Dr Chris Parker will attend the
35th steering committee of VICH – International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products in Tokyo, Japan.
VICH is a trilateral program between the EU, Japan and the USA, with a number of countries—including Australia—being observer members. We will be attending the meetings as an observer member, contributing to discussions and promoting coordination between national regulatory agencies. VICH guidance is used as a reference for our regulatory work and we have adopted several VICH guidelines where they are suitable to Australian conditions.
APVMA archive content to be decommissioned in December 2017
A recent review found that our archive site is not frequently visited and that the majority of visits to the archive are made only to view application summaries. As a result of this data—and to ensure that our content is current and easy to access—we intend to decommission the APVMA archive site in December 2017. As an exception, application summaries will remain accessible online.
We invite you to provide feedback and outline any concerns you might have with our plans. If you would like us to consider specific content that you believe is of value, please submit your feedback with the URL address of the content and a rationale as to why that content should be kept. Appropriate content will be migrated to the current APVMA website. All content that is found to be out-dated or inconsistent with current information will be removed.
Our intention to decommission the archive site is part of the ongoing commitment to improve user experience through enhancing the information and functionality of our website.
Please email your feedback to firstname.lastname@example.org by Friday 17 November 2017.
Procymidone Human Health Risk Assessment report published
The Reconsideration of Procymidone: Human health risk assessment (including Toxicology and Work Health Safety) is now available on the APVMA website.
The report concludes that there is no objection on human health grounds to the continued registration of existing procymidone products in Australia and identified some additions and amendments to the existing First Aid Instructions and Safety Directions (FAISD).
Improving our business and simplifying registration for clients
The APVMA is delivering a range of projects funded by the Department of Agriculture and Water Resources, and the Australian Government’s Agricultural Competitiveness White Paper to improve our business and simplify the registration process for our clients and stakeholders.
View our progress on these projects by visiting the information on our website.
Reminder—open for public consultation
We regularly seek input throughout chemical registration and review processes, and other operational and regulatory processes. We are currently seeking input on the following open consultations:
- Proposal to amend Schedule 20 of the revised Australia New Zealand Food Standards Code - 28 November 2017
- Trade Advice Notice on the proposed use of the product Ceriax Fungicide containing fluxapyroxad on wheat - 29 November 2017
- Phone our general enquiries number: +61 2 6210 4701
- Email: email@example.com
- Our mailing address is:
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston, Australian Capital Territory 2604
Add us to your address book